Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III Study

Gyu Chul Oh; Jung-Kyu Han; Ki Hoon Han; Min-Su Hyon; Joon Hyung Doh; Moo Hyun Kim; Jin-Ok Jeong; Jang-Ho Bae; Sang Hyun Kim; Byung-Su Yoo; Sang Hong Baek; Moo-Yong Rhee; Sang-Hyun Ihm; Jung Hoon Sung; Young Jin Choi; Soo-Joong Kim; Kyung-Soon Hong; Byoung Kwon Lee; JangHyun Cho; Eun Seok Shin; Jay Young Rhew; Hyunsu Kim; Hyo-Soo Kim

doi:10.1016/j.clinthera.2018.03.010

Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III Study

Clinical Therapeutics ◽

10.1016/j.clinthera.2018.03.010 ◽

2018 ◽

Vol 40 (5) ◽

pp. 676-691.e1 ◽

Cited By ~ 2

Author(s):

Gyu Chul Oh ◽

Jung-Kyu Han ◽

Ki Hoon Han ◽

Min-Su Hyon ◽

Joon Hyung Doh ◽

...

Keyword(s):

Combination Therapy ◽

Fixed Dose Combination ◽

Phase Iii ◽

Fixed Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Korean Patients ◽

Phase Iii Study ◽

Dose Combination

Download Full-text

Comparison of the Efficacy and Safety of Atorvastatin 40 mg/ω-3 fatty acids 4 g Fixed-Dose Combination and Atorvastatin 40 mg Monotherapy in Hypertriglyceridemic Patients Who Poorly Respond to Atorvastatin 40 mg Monotherapy: An 8-Week, Multicenter, Randomized, Double-Blind Phase III Study

Clinical Therapeutics ◽

10.1016/j.clinthera.2021.07.001 ◽

2021 ◽

Author(s):

Jong Shin Woo ◽

Soon Jun Hong ◽

Dong Hoon Cha ◽

Kee Sik Kim ◽

Moo Hyun Kim ◽

...

Keyword(s):

Fatty Acids ◽

Fixed Dose Combination ◽

Phase Iii ◽

Fixed Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Study ◽

Dose Combination

Download Full-text

Efficacy and Safety of a Fixed-Dose Combination of Candesartan and Rosuvastatin on Blood Pressure and Cholesterol in Patients With Hypertension and Hypercholesterolemia: A Multicenter, Randomized, Double-Blind, Parallel Phase III Clinical Study

Clinical Therapeutics ◽

10.1016/j.clinthera.2019.05.007 ◽

2019 ◽

Vol 41 (8) ◽

pp. 1508-1521 ◽

Cited By ~ 3

Author(s):

Kyoung Im Cho ◽

Bo Hyun Kim ◽

Yong Hyun Park ◽

Jeong-Cheon Ahn ◽

Sang Hyun Kim ◽

...

Keyword(s):

Blood Pressure ◽

Clinical Study ◽

Fixed Dose Combination ◽

Phase Iii ◽

Fixed Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Dose Combination

Download Full-text

Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)

Drug Design Development and Therapy ◽

10.2147/dddt.s112873 ◽

2016 ◽

Vol Volume 10 ◽

pp. 2599-2609 ◽

Cited By ~ 10

Author(s):

Jin-Sun Park ◽

Joon-Han Shin ◽

Taek Jong Hong ◽

Hong-Seog Seo ◽

Wan-Joo Shim ◽

...

Keyword(s):

Combination Therapy ◽

Factorial Design ◽

Moderate Hypertension ◽

Olmesartan Medoxomil ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Efficacy And Safety ◽

Design Study ◽

Double Blind ◽

Dose Combination

Download Full-text

Efficacy and safety of fixed-dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double-blind, controlled, phase 3 trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13491 ◽

2018 ◽

Vol 21 (1) ◽

pp. 103-111 ◽

Cited By ~ 1

Author(s):

Ji Cheol Bae ◽

Kyung Wan Min ◽

Yong Hyun Kim ◽

Kyoung-Ah Kim ◽

Eun-Gyoung Hong ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Dose Combination

Download Full-text

Blood Pressure and Cholesterol-lowering Efficacy of a Fixed-dose Combination With Irbesartan and Atorvastatin in Patients With Hypertension and Hypercholesterolemia: A Randomized, Double-blind, Factorial, Multicenter Phase III Study

Clinical Therapeutics ◽

10.1016/j.clinthera.2016.09.005 ◽

2016 ◽

Vol 38 (10) ◽

pp. 2171-2184 ◽

Cited By ~ 13

Author(s):

Sang-Hyun Kim ◽

Sang-Ho Jo ◽

Sang-Cheol Lee ◽

Sung-Yoon Lee ◽

Myung-Ho Yoon ◽

...

Keyword(s):

Blood Pressure ◽

Fixed Dose Combination ◽

Phase Iii ◽

Fixed Dose ◽

Double Blind ◽

Cholesterol Lowering ◽

Multicenter Phase ◽

Phase Iii Study ◽

Dose Combination

Download Full-text

Effects of Fixed-Dose Combination of Low-Intensity Rosuvastatin and Ezetimibe Versus Moderate-Intensity Rosuvastatin Monotherapy on Lipid Profiles in Patients With Hypercholesterolemia: A Randomized, Double-Blind, Multicenter, Phase III Study

Clinical Therapeutics ◽

10.1016/j.clinthera.2021.07.016 ◽

2021 ◽

Author(s):

Seung-Ah Lee ◽

Weon Kim ◽

Taek Jong Hong ◽

Youngkeun Ahn ◽

Moo Hyun Kim ◽

...

Keyword(s):

Lipid Profiles ◽

Fixed Dose Combination ◽

Phase Iii ◽

Moderate Intensity ◽

Fixed Dose ◽

Double Blind ◽

Low Intensity ◽

Multicenter Phase ◽

Phase Iii Study ◽

Dose Combination

Download Full-text

A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy

Annals of Oncology ◽

10.1093/annonc/mdu101 ◽

2014 ◽

Vol 25 (7) ◽

pp. 1328-1333 ◽

Cited By ~ 133

Author(s):

M. Aapro ◽

H. Rugo ◽

G. Rossi ◽

G. Rizzi ◽

M.E. Borroni ◽

...

Keyword(s):

Emetogenic Chemotherapy ◽

Nausea And Vomiting ◽

Fixed Dose Combination ◽

Phase Iii ◽

Fixed Dose ◽

Efficacy And Safety ◽

Moderately Emetogenic Chemotherapy ◽

Phase Iii Study ◽

Dose Combination

Download Full-text

Comparative Efficacy and Safety Profile of Amlodipine 5 mg/Losartan 50 mg Fixed-Dose Combination and Amlodipine 10 mg Monotherapy in Hypertensive Patients Who Respond Poorly to Amlodipine 5 mg Monotherapy: An 8-Week, Multicenter, Randomized, Double-Blind Phase III Noninferiority Study

Clinical Therapeutics ◽

10.1016/j.clinthera.2011.11.007 ◽

2011 ◽

Vol 33 (12) ◽

pp. 1953-1963 ◽

Cited By ~ 8

Author(s):

Seok-Min Kang ◽

Jong-Chan Youn ◽

Shung Chull Chae ◽

Chang Gyu Park ◽

Joo Young Yang ◽

...

Keyword(s):

Safety Profile ◽

Fixed Dose Combination ◽

Phase Iii ◽

Fixed Dose ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Double Blind ◽

Hypertensive Patients ◽

Dose Combination

Download Full-text

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

Case Medical Research ◽

10.31525/ct1-nct04033354 ◽

2019 ◽

Author(s):

Keyword(s):

Stage Iiib ◽

Phase Iii ◽

Line Treatment ◽

Efficacy And Safety ◽

First Line ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

A Randomized, Double-blind, Placebo‑Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Case Medical Research ◽

10.31525/ct1-nct04063163 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

Extensive Stage

Download Full-text